Dose Response Study of Patients With Erythematous Rosacea

Inclusion Criteria: * male or females at least 18 years of age * diagnosis of stable erythematous rosacea * \< 3 inflammatory lesions * in good general health * females must be non-pregnant and non-lactating * must be willing to sign a consent form Exclusion Criteria: * have ocular, phymatous or other types of rosacea * allergy to any ingredient in study drug * participation in other investigational studies within 30 days of enrollment * use of systemic steroids within 28 days of Baseline * use of tetracycline antibiotics within 28 days of baseline * use of products containing oxymetazoline within 14 days of baseline * use of topical steroids witin treatment area 14 days prior to baseline * use of Rx or OTC products for treatment of acne or rosacea within 14 days of baseline * use of any product for reducing redness within the treatment area witin 14 days prior to baseline * use of monoamine oxidase (MAO) inhibitors * use of niacin \>/= 500mg/day